Evidence map›Paper›PMID 29733303›Full record

ArticleJournal of visualized experiments : JoVE2018

An In Ovo Model for Testing Insulin-mimetic Compounds.

Renate Haselgrübler, Flora Stübl, Verena Stadlbauer, Peter Lanzerstorfer, Julian Weghuber

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Identification of Plant Phenolics fromJournal of agricultural and food chemistry · 2025
    Article
  2. Article
  3. A comprehensiveFrontiers in pharmacology · 2024
    Review
  4. (Bio)active Compounds in Daisy Flower (Molecules (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Avens Root (Frontiers in pharmacology · 2021
    Article
  9. Insulin Mimetic Properties of Extracts Prepared fromMolecules (Basel, Switzerland) · 2018
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Renate HaselgrüblerUniversity of Applied Sciences Upper Austria.
Flora StüblUniversity of Applied Sciences Upper Austria.
Verena StadlbauerUniversity of Applied Sciences Upper Austria; Austrian Competence Center for Feed and Food Quality, Safety and Innovation.
Peter LanzerstorferUniversity of Applied Sciences Upper Austria.
Julian WeghuberUniversity of Applied Sciences Upper Austria; Austrian Competence Center for Feed and Food Quality, Safety and Innovation; julian.weghuber@fh-wels.at.
University of Applied Sciences Upper Austria · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated blood glucose levels in type 2 diabetes mellitus (T2DM), a complex and multifactorial metabolic disease, are caused by insulin resistance and β-cell failure. Various strategies, including the injection of insulin or the usage of insulin-sensitizing drugs, were pursued to treat T2DM or at least reduce the symptoms. In addition, the application of herbal compounds has attracted increasing attention. Thus, it is necessary to find efficient test systems to identify and characterize insulin-mimetic compounds. Here we developed a modified chick embryo model, which enables testing of synthetic compounds and herbal extracts with insulin-mimetic properties. Using a fluorescence microscopy-based primary screen, which quantifies the translocation of Glucose transporter 4 (Glut4) to the plasma membrane, we were able to identify compounds, mainly herbal extracts, which lead to an increase of intracellular glucose concentrations in adipocytes. However, the efficacy of these substances requires further verification in a living organism. Thus, we used an in-ovo approach to identify their blood glucose-reducing properties. The approval by an ethics committee is not needed since the use of chicken embryos during the first two-thirds of embryonic development is not considered an animal experiment. Here, the application of this model is described in detail.

Indexed as

AnimalsChick EmbryoChickensDiabetes Mellitus, Type 2Disease Models, AnimalFemaleInsulinInsulin

Identifiers

PMID29733303
PMCPMC6100700
OpenAlexW2801043865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.